$2.46
1.01%
Nasdaq, Sep 29, 01:59 pm EDT. Market open.
ISIN
US0088751062
Symbol
DOMH

AIkido Pharma Inc Stock price

$2.48
+0.09 3.77% 1M
-0.14 5.18% 6M
-1.68 40.37% YTD
-3.61 59.29% 1Y
+0.64 34.53% 3Y
-9.37 79.07% 5Y
-60.61 96.07% 10Y
-252,937.11 100.00% 20Y
Nasdaq, Closing price Mon, Sep 28 2026
+0.15 6.21%
ISIN
US0088751062
Symbol
DOMH
Industry

Is AIkido Pharma Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.

Key metrics

Basic
Market capitalization
$60.1m
Enterprise Value
$26.1m
Net debt
-
Cash
-
Shares outstanding
-
Valuation (TTM | estimate)
P/E
negative
P/S
0.5 | -
EV/Sales
0.2 | -
EV/FCF
negative
P/B
0.9
Dividends
DPS
$0.44
Yield 1Y | 5Y
0.0% | 0.0%
Growth 1Y | 5Y
- | -
Payout 1Y | 3Y
-28.3% | -5.3%
Increased
1 Year
Financials (TTM | estimate)
Revenue
$133.5m | -
EBITDA
$-43.0m
EBIT
$-43.1m
Net Income
$-69.3m
Free Cash Flow
$-17.0m
Growth (TTM | estimate)
Revenue
152.8% | -
EBITDA
25.0%
EBIT
25.0%
Net Income
-264.5%
Free Cash Flow
-141.3%
Margin
Gross
-
EBITDA
-32.2%
EBIT
-32.3%
Net
-51.9%
Free Cash Flow
-12.7%
Financial Health
Equity Ratio
-
Return on Equity
-
ROCE
-56.0%
ROIC
-106.3%
Debt/Equity
-
More
EPS
$-3.0
FCF per Share
$-1.1
Short interest
6.7%
Employees
36
Rev per Employee
$3.4m

AIkido Pharma Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a AIkido Pharma Inc forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a AIkido Pharma Inc forecast:

Buy
86%
Hold
14%

Financial data from AIkido Pharma Inc

Jun '26
+/-
%
133 133
153% 153%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 171 171
55% 55%
128%
- Research and Development Expense - -
-
-
-43 -43
25% 25%
-32%
- Depreciation and Amortization 0.09 0.09
18% 18%
0%
EBIT (Operating Income) EBIT -43 -43
25% 25%
-32%
Net Profit -69 -69
264% 264%
-52%

In millions USD.

Don't miss a Thing! We will send you all news about AIkido Pharma Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

AIkido Pharma Inc Stock News

Neutral
PRNewsWire
●
12 days ago
NEW YORK, Sept. 17, 2026 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) ("Dominari" or the "Company") today announced a share repurchase program of up to Five Million ($5,000,000.00) Dollars of its outstanding common stock.
Neutral
PRNewsWire
●
about 2 months ago
Operating loss narrows to $1.1 million for the second quarter as compared to $14.9 million for Q2 2025 NEW YORK, Aug. 11, 2026 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) ("Dominari" or the "Company"), today announced highlights of its financial results for the quarter ended March 31, 2026, which were filed with the Securities and Exchange Commission ("SEC") in the Company's quarterly...
Neutral
GlobeNewsWire
●
about 2 months ago
Chairman Kyle Wool, a veteran Wall Street executive, to lead the Company's pursuit of its anticipated initial business combination phase New York, New York, Aug. 05, 2026 (GLOBE NEWSWIRE) -- New America Acquisition I Corp. (NYSE: NWAX) (the “Company”) today announced that Kevin McGurn has resigned as Chief Executive Officer and as a member of the Board of Directors of the Company, effective Aug...
More AIkido Pharma Inc News

Company Profile

Spherix Incorporated, a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. Its pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. The company's platform consists of patented technology from leading universities and researchers and in the process of developing an innovative therapeutic drug platform through partnerships with world renowned educational institutions, including The University of Texas at Austin and Wake Forest University. It has a scientific research agreement with The University of Texas Southwestern Medical Center to use machine learning to find genetic markers in people that indicate an increased risk of developing pancreatic cancer. Spherix Incorporated was founded in 1967 and is based in New York, New York.

Head office United States
CEO Mr. Hayes
Employees 36
Founded 1967
Website www.dominariholdings.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today